Menu

• Ask a Health Expert about RECTAL CANCER METASTATIC
• Post Your Side Effect related to RECTAL CANCER METASTATIC
• RECTAL CANCER METASTATIC and FDA Warnings
• RECTAL CANCER METASTATIC in Patients Wiki
• Report RECTAL CANCER METASTATIC in Drug Side Effect Survey

RECTAL CANCER METASTATIC side effect

What is RECTAL CANCER METASTATIC ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Xeloda Side Effects Report #5612222-2
Health Professional from UNITED STATES reported XELODA problem on Jan 25, 2008. Male patient, 69 years of age, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic, . XELODA dosage: unknown. Patient died on 12/10/2007.

Pioglitazone Side Effects Report #5407418-9
PIOGLITAZONE problem was reported by a Consumer or non-health professional from CANADA on July 30, 2007. Male patient, 78 years of age, was diagnosed with type 2 diabetes mellitus and was treated with PIOGLITAZONE. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic, . PIOGLITAZONE dosage: 15 MG (15 MG, 1 IN 1 D), PER ORAL, 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with METOPROLOL SUCCINATE, IMIPRAMINE, GLICLAZIDE, ENALAPRIL MALEATE, METFORMIN, MAGNESIUM OXIDE, TRENTAL. Patient died.

Venlafaxine Side Effects Report #5401056-X
Physician from GERMANY reported VENLAFAXINE problem on July 27, 2007. Female patient, weighting 154.3 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic, . VENLAFAXINE dosage: 150 MG DAILY. Patient recovered.

Venlafaxine Side Effects Report #5401056-X
VENLAFAXINE problem was reported by a Physician from GERMANY on July 27, 2007. Female patient, weighting 154.3 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic, . VENLAFAXINE dosage: 150 MG DAILY. Patient recovered.


Venlafaxine Side Effects Report #5361479-4
Health Professional from GERMANY reported VENLAFAXINE problem on June 12, 2007. Female patient was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic, . VENLAFAXINE dosage: 150 MG DAILY. Patient recovered.

Lidocaine Side Effects Report #5535109-2
LIDOCAINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 28, 2007. Male patient, 87 years of age, weighting 143.3 lb, was diagnosed with post herpetic neuralgia and was treated with LIDOCAINE. After drug was administered, patient experienced the following problems/side effects: gastritis, prostate cancer, rectal cancer metastatic, . LIDOCAINE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, ASPIRIN, CLOPIDOGREL, DILTIAZEM, FERROUS SULPHATE, OMEPRAZOLE, SIMVASTATIN, VALSARTAN. Patient was hospitalized. Patient died on 07/17/2007.

Xeloda Side Effects Report #5374210-3
Health Professional from UNITED STATES reported XELODA problem on July 03, 2006. Male patient, 67 years of age, weighting 143.1 lb, was diagnosed with rectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: dehydration, rectal cancer metastatic, . XELODA dosage: 1500 MG 2 PER DAY ORAL. During the same period patient was treated with AVASTIN, OXALIPLATIN, ATENOLOL. Patient died on 06/24/2006.

Niaspan Side Effects Report #5261389-7
NIASPAN problem was reported by a Physician from UNITED STATES on Feb 19, 2007. Male patient, 55 years of age, weighting 127.0 lb, was diagnosed with high density lipoprotein decreased, metabolic syndrome and was treated with NIASPAN. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, metastases to liver, rectal cancer metastatic, rectal haemorrhage, . NIASPAN dosage: 2000 MG QD PO. During the same period patient was treated with PIOGLITAZONE, ATENOLOL, SPIRONOLACTONE, QUINAPRIL, ASPIRIN. Patient recovered.